Abyss Pharma Private Limited

Abyss Pharma Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U24232DL1997PTC087663 Incorporated 03 June 1997 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2024
₹19.15 Cr
▲ 7% YoY
Net profit · FY 2024
₹34.05 Lakh
Net margin 1.8%
EBITDA · FY 2024
₹82.69 Lakh
EBITDA margin 4.3%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹9.95 Lakh
Issued & subscribed
Open charges
₹50.77 Lakh
Secured borrowings
Company age
29 yrs
Est. 1997
Employees · EPFO
19
Provident fund records

About Abyss Pharma Private Limited

Data last updated:

Abyss Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 June 1997 and has been in existence for over 29 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL1997PTC087663. Its GSTIN is 07AABCA8551E2ZU (Delhi). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9.95 Lakh. It is led by directors Nitin Gupta and Vimal Kumar Gupta.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 121 Phase – I Mayapuri Industrial Area, New Delhi, Delhi, India – 110064.

As per the financials filed for FY 2024, the company reported a revenue of ₹19.15 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹34.05 Lakh (net margin 1.8%) and EBITDA of ₹82.69 Lakh (EBITDA margin 4.3%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 30% over five years.

The company has about 19 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Abyss Pharma. As per MCA filings, the company has open charges of ₹50.77 Lakh on record. Court records list 4 cases involving the company, including 2 filed by the company and 2 filed against it; 1 case is pending.

Abyss Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-10-0001260). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website abysspharma.com.

Company details

CIN U24232DL1997PTC087663
Registration Number 087663
Incorporation Date 03 June 1997
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-10-0001260

Recognitions & Rankings of Abyss Pharma

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-DL-10-0001260

Contact details

Abyss Pharma Private Limited's registered office is in New Delhi, Delhi. Its website is abysspharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    B – 121 Phase – I Mayapuri Industrial Area, New Delhi, Delhi, India – 110064
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Abyss Pharma Private Limited, buy the company report.

Comprehensive company report
Abyss Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Abyss Pharma operates one associated brand: Abyss Pharma. Each brand links to its own profile.

BrandDescriptionWebsite
Manufacturing and marketing of pharmaceutical formulations in India and international markets.abysspharma.com

Business activity

The main business activity of Abyss Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Abyss Pharma Private Limited, buy the company report.

Financials of Abyss Pharma Private Limited

FY 2025 filings available

Abyss Pharma Private Limited reported revenue of ₹19.15 Cr (up 7% YoY) for FY 2024.

Revenue · FY 2024
₹19.15 Cr ▲ 7%
Net profit · FY 2024
₹34.05 Lakh margin 1.8%
EBITDA · FY 2024
₹82.69 Lakh margin 4.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 13%
5 years · compounded
▲ 30%
EBITDA CAGR growth
1 year
▲ 29%
3 years · compounded
▲ 45%
5 years · compounded
▲ 61%

Revenue has grown at a compounded annual rate (CAGR) of 30% over five years, including 7% growth in the latest year. EBITDA rose 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹19.15 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹82.69 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹34.05 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin4.3%
Net Profit Margin1.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Abyss Pharma Private Limited, buy the company report.

Board of directors of Abyss Pharma Private Limited

Abyss Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Nitin GuptaDirector30 Nov 20223 Years 10 MonthsCurrent
Vimal Kumar GuptaDirector03 Jun 199729 Years 4 MonthsCurrent

Peer comparison

Abyss Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Dr.Jrk's Research and Pharmaceuticals Private Limited₹19.15 Cr (FY 2025)4.0%Chennai, Tamil Nadu, India
Abyss Pharma Private Limitedthis company₹19.15 Cr (FY 2024)₹34.05 Lakh1.8%7.0%19New Delhi, Delhi, India
Srinija Drugs Private Limited₹19.09 Cr (FY 2024)64.0%Andhra Pradesh, India
Omega Biotech Limited₹19.07 Cr (FY 2024)10.0%New Delhi, Delhi, India
Maha Avtar Health Care Private Limited₹19.06 Cr (FY 2025)43.0%Delhi, India

To see the full peer comparison of Abyss Pharma Private Limited, buy the company report.

Auditor

Abyss Pharma Private Limited is audited by MAHESH YADAV & ASSOCAITES for the financial year 2024.

Auditor firmFinancial yearFirm registration number
MAHESH YADAV & ASSOCAITESFY 2024026771N

Shareholding

The shareholding of Abyss Pharma Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Abyss Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹50.77 Lakh
Satisfied charges
None
Breakdown by lending institutions
Others₹0.36 Cr
Hdfc Bank Limited₹0.15 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
20 Nov 2023100845724Hdfc Bank Limited₹15 LakhOpen
16 Nov 2021100508508Others₹35.77 LakhOpen

Total charge records: 2 View all charges

MSME payment delays

Abyss Pharma Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 5 overdue payments to 3 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (3 of 3)

SupplierAmount dueDue sinceReported on
Premier Extrusions
an individual supplier
Indo Pack Limited

To see the full MSME payment records of Abyss Pharma Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Abyss Pharma Private Limited has a workforce of 19 employees on its EPFO records as of Feb 17, 2025, across 1 active EPFO establishment.

Employee count
19
Active EPFO establishments
1
Employee growth
11.76%

GST

Abyss Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
07AABCA8551E2ZUDelhiActive25 Jul 2017

To see the full GST registrations and return filing status of Abyss Pharma Private Limited, buy the company report.

Recent activity

Abyss Pharma Private Limited has 4 board changes on record since 1997: 2 appointments and 2 cessations. The latest: Neeraj Gupta ceased to be Director on 30 Nov 2022.

AGM
Abyss Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Abyss Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 15.00 Lakh with Charge ID 100845724 was registered on 20 Nov 2023.
Ceased
Neeraj Gupta ceased to be Director.
Appointed
Nitin Gupta was appointed as Director.
Charges
A charge with Others amounted to Rs. 35.77 Lakh with Charge ID 100508508 was registered on 16 Nov 2021.
Ceased
Nitin Gupta ceased to be Director.
Appointed
Vimal Kumar Gupta was appointed as Director.
Incorporation
03 Jun 1997
Abyss Pharma Private Limited was registered on 03 Jun 1997 with Roc Delhi & aged 29 years 4 months as per MCA records.

Frequently asked questions

Abyss Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 June 1997 (29+ years old) and is registered under CIN U24232DL1997PTC087663.

Abyss Pharma has 2 current directors:

The latest financial statements of Abyss Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Abyss Pharma is 07AABCA8551E2ZU, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Abyss Pharma is U24232DL1997PTC087663. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Abyss Pharma has 4 court cases on record: 2 filed by the company and 2 filed against it. 1 is pending. Most are in the district courts.

Abyss Pharma was incorporated on 03 June 1997, making it 29+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Abyss Pharma by revenue are Dr.Jrk's Research and Pharmaceuticals Private Limited, Srinija Drugs Private Limited, Omega Biotech Limited, Maha Avtar Health Care Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Neeraj Gupta ceased to be Director on 30 Nov 2022. Nitin Gupta was appointed as Director on 30 Nov 2022. Nitin Gupta ceased to be Director on 15 Jan 2021. Abyss Pharma has 4 board changes on record in total.

Yes, Abyss Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-DL-10-0001260).

Abyss Pharma has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 5 overdue payments to 3 micro and small suppliers. The latest return was filed on 08 Jun 2019.

Abyss Pharma can be reached through the website abysspharma.com. Its registered office is in New Delhi, Delhi, India.